Benign and Malignant Tumors of the Liver

  • Emery A. Minnard
  • Yuman Fong


One-eighth of the population of the United States is over the age of 65, and this small portion suffers one-half of all cancers diagnosed. It was estimated that by the year 2005, more than one-fifth of the U.S. population would be over the age of 65.1 This demographic change alone will increase the number of cancers in America by approximately 30 %,2,3 making no other single factor as important as age for cancer incidence.


Liver Metastasis Liver Resection Hepatic Resection Liver Tumor Liver Regeneration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adkins RB Jr, Scott HW Jr (eds). Surgical Care for the Elderly. Baltimore: Williams & Wilkins, 1988.Google Scholar
  2. 2.
    Koruda MJ, Sheldon GF. Surgery in the aged. Curr Surg 1992:293–331.Google Scholar
  3. 3.
    Greenfield LJ. Surgery of the Aged. Philadelphia: Saunders, 1975.Google Scholar
  4. 4.
    Brooks B. Surgery in patients of advanced age. Ann Surg 1937;105:481–501.PubMedCrossRefGoogle Scholar
  5. 5.
    Fong Y, Blumgart LH, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 1995;222:426–437.PubMedGoogle Scholar
  6. 6.
    Parker SL. Cancer statistics, 1996. CA Cancer J Clin 1996;65:5–27.CrossRefGoogle Scholar
  7. 7.
    Fortner JG, Silva JS, Cox EB, et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 1984;199: 306–316.PubMedCrossRefGoogle Scholar
  8. 8.
    Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:492–505.CrossRefGoogle Scholar
  9. 9.
    Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994;116:703–711.PubMedGoogle Scholar
  10. 10.
    Ezaki T, Yukaya H, Ogawa Y Evaluation of hepatic resection for hepatocellular carcinoma in the elderly. Br J Surg 1987;74:471–473.PubMedCrossRefGoogle Scholar
  11. 11.
    Yanaga K, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y, Sugimachi K. Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 1988;155: 238–241.PubMedCrossRefGoogle Scholar
  12. 12.
    Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg 1990;211:141–145.PubMedCrossRefGoogle Scholar
  13. 13.
    Mentha G, Huber O, Robert J, Klopfenstein C, Egeli R, Rohner A. Elective hepatic resection in the elderly. Br J Surg 1992;79:557–559.PubMedCrossRefGoogle Scholar
  14. 14.
    Nagasue N, Chang YC, Takemoto Y, Taniura H, Kohno H, Nakamura T. Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery 1993;113: 148–154.PubMedGoogle Scholar
  15. 15.
    Takenaka K, Shimada M, Higahi H, et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg 1994; 129:846–850.PubMedCrossRefGoogle Scholar
  16. 16.
    Karl RC, Smith SK, Fabri PJ. Validity of major cancer operations in elderly patients. Ann Surg Oncol 1995;2:107–113.PubMedCrossRefGoogle Scholar
  17. 17.
    Fong Y, Brennan MF, Cohen AE, Heffernan N, Freiman A, Blumgart LH. Liver resection in the elderly. Br J Surg 1997;84:1386–1390.PubMedCrossRefGoogle Scholar
  18. 18.
    Fong Y, Blumgart LH, Cohen A, Fortner J, Brennan MF. Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 1994;220:657–662.PubMedCrossRefGoogle Scholar
  19. 19.
    Schwartz SI. Biliary tract surgery and cirrhosis: a critical combination. Surgery 1981;90:577–583.PubMedGoogle Scholar
  20. 20.
    Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OFW. The effect of age upon liver volume and apparent blood flow in healthy man. Hepatology 1989; 9:297–301.PubMedCrossRefGoogle Scholar
  21. 21.
    Asano K, Nakamura M, Asano A, Sato T, Tauchi H. Quantitation of changes in mitochondrial DNA during aging and regeneration of rat liver using non-radioactive DNA probes. Mech Ageing Dev 1992;62:85–98.CrossRefGoogle Scholar
  22. 22.
    Mooney H, Roberts R, Cooksley WGE, Halliday JW, Powell LW. Alterations in the liver with ageing. Clin Gastroenterol 1985;14:757–771.PubMedGoogle Scholar
  23. 23.
    Yamamoto K, Takenaka K, Matsumata T, et al. Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology 1997;44:514–518.PubMedGoogle Scholar
  24. 24.
    Carrillo MC, Carnovale CE, Favre C, Monti JA, Scapini C. Hepatic protein synthesis and serum amino acid levels during liver regeneration in young and old malnourished rats. Mech Ageing Dev 1996;91:55–64.PubMedCrossRefGoogle Scholar
  25. 25.
    Schapiro H, Hotta SS, Outten WE, Klein AW. The effect of aging on rat liver regeneration. Experientia 1982;38: 1075–1076.PubMedCrossRefGoogle Scholar
  26. 26.
    Beyer HS, Sherman R, Zieve L. Aging is associated with reduced liver regeneration and diminished thymidine kinase mRNA content and enzyme activity in the rat. J Lab Clin Med 1991;117:101–108.PubMedGoogle Scholar
  27. 27.
    Fry M, Silber J, Loeb LA, Martin GM. Delayed and reduced cell replication and diminishing levels of DNA polymerase-alpha in regenerating liver of aging mice. J Cell Physiol 1984;118:225–232.PubMedCrossRefGoogle Scholar
  28. 28.
    Taguchi T, Ohashi M. Age-associated changes in the template-reading fidelity of DNA polymerase alpha from regerating rat liver. Mech Ageing Dev 1996;92:143–157.PubMedCrossRefGoogle Scholar
  29. 29.
    Piantanelli L, Ermini M, Ricciotti R. Histone phosphorylation after partial hepatectomy in young and old rats. Experientia 1974;30:210–211.Google Scholar
  30. 30.
    Oh YH, Conard RA. Effect of aging on histone acetylation of the normal and regenerating rat liver. Life Sci 1972;11: 1207–1214.CrossRefGoogle Scholar
  31. 31.
    Ferrucci JT. Liver tumor imaging. Cancer 1991;67:1189–1195.PubMedCrossRefGoogle Scholar
  32. 32.
    Larson RE, Semelka RC. Magnetic resonance imaging of the liver. Top Magn Reson Imaging 1995;7(2):71–81.PubMedCrossRefGoogle Scholar
  33. 33.
    Nichols FC, Van Heerden JA, Weiland LA. Benign liver tumors. Surg Clin North Am 1989;69:290–313.Google Scholar
  34. 34.
    Leese T, Farges O, Bismuth H. Liver cell adenomas: a 12 year surgical experience from a specialist hepatobiliary unit. Ann Surg 1988;208:558–564.PubMedCrossRefGoogle Scholar
  35. 35.
    Schwartz SI, Husser WC. Cavernous hemangioma of the liver. Ann Surg 1987;205:456.PubMedCrossRefGoogle Scholar
  36. 36.
    Kuo PC, Lewis WD, Jenkins RL. Treatment of giant hemangiomas of the liver by enucleation. J Am Coll Surg 1994; 178:49.PubMedGoogle Scholar
  37. 37.
    Trastek VF, Van Heerden JA, Sheedy PFI, Adson MA. Cavernous hemangiomas of the liver: resect or observe? Am J Surg 1983;145:49.PubMedCrossRefGoogle Scholar
  38. 38.
    Yamagata M, Kanematsu T, Matsumata T, et al. Management of hemangioma of the liver: comparison between surgery and observation. Br J Surg 1991;78:1223.PubMedCrossRefGoogle Scholar
  39. 39.
    Gaspar L, Mascarenhas F, de Costa MS, Dias JS, Alfonso JG, Silvestre ME. Radiation therapy in the unresectable cavernous hemangioma of the liver. Radiother Oncol 1993; 29:45–50.PubMedCrossRefGoogle Scholar
  40. 40.
    Biswal BM, Sandhu M, Lai P, Bai CS. Role of radiotherapy in cavernous hemangioma of liver. Indian J Gastroenterol 1995;14:95–98.PubMedGoogle Scholar
  41. 41.
    Yamamoto T, Kawarda Y, Yano T, Noguichi T, Mizumoto R. Spontaneous rupture of hemangioma of the liver: treatment with transcatheter hepatic arterial embolization. Am J Gastroenterol 1991;86:1645–1649.PubMedGoogle Scholar
  42. 42.
    McKenna RJ Sr, Murphy GP. Cancer Surgery. Philadelphia: Lippincott, 1994.Google Scholar
  43. 43.
    Farmer DG, Rosove MH, Shaked A, Busuttil RW. Treatment of hepatocellular carcinoma. Ann Surg 1994;219:236–247.PubMedCrossRefGoogle Scholar
  44. 44.
    Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small carcinomas: efficacy of various imaging procedures in 100 patients. Am J Radiol 1990;155:49–54.Google Scholar
  45. 45.
    Blumgart LH. Liver resection: liver and biliary tumours. In: Blumgart LH (ed) Surgery of the Liver and Biliary Tract, 1st ed. New York: Churchill Livingstone, 1988:97:1251–1280.Google Scholar
  46. 46.
    Parker GA, Lawrence W Jr, Horsley JS III, et al. Intraoperative ultrasound of the liver affects operative decision making. Ann Surg 1989;209:569–577.PubMedCrossRefGoogle Scholar
  47. 47.
    Iwatsuki S, Starzl TE. Personal experience with 411 hepatic resections. Ann Surg 1988;4:421–434.CrossRefGoogle Scholar
  48. 48.
    Fong Y, Blumgart LH, Zakim D, Boyer TD (eds) Surgical therapy of liver cancer. In: Hepatology, 3rd ed. Philadelphia: Saunders, 1996;51:1548–1564.Google Scholar
  49. 49.
    Iwatsuki S, Gordon RD, Shaw BW Jr, et al. Role of liver transplantation in cancer therapy. Ann Surg 1985;202: 401–407.PubMedCrossRefGoogle Scholar
  50. 50.
    Ravikumar TS, Kane R, Cady B, Jenkins R, Clouse M, Steele G Jr. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991;126:1520–1523.PubMedCrossRefGoogle Scholar
  51. 51.
    Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992;163:387–394.PubMedCrossRefGoogle Scholar
  52. 52.
    Raoul JL, Heresbach D, Bretagne JF, et al. Chemoembolization of hepatocellular carcinomas. Cancer 1992;70:585–589.PubMedCrossRefGoogle Scholar
  53. 53.
    Brown K, Nevins AB, Getradjman G, et al. Particle embolization of hepatocellular carcinoma. J Vasc Int Radiol 1998;9:822–828.CrossRefGoogle Scholar
  54. 54.
    Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study of 207 patients. Cancer 1992; 69:925–929.PubMedCrossRefGoogle Scholar
  55. 55.
    Sitzman JV, Abrams R. Improved survival for hepatocellular cancer with combination surgery and multimodal treatment. Ann Surg 1993;217:149–154.CrossRefGoogle Scholar
  56. 56.
    Hughes KS, Simons R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multiinsti-tutional study of patterns of recurrence. Surgery 1986;100: 278–284.PubMedGoogle Scholar
  57. 57.
    Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285–288.PubMedGoogle Scholar
  58. 58.
    Doroshow JH, Multhauf P, Leong L, et al. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 1990;8:491–501.PubMedGoogle Scholar
  59. 59.
    Colucci G, Maiello E, Giuliani F, et al. Biochemical modulation of 5-fluorouracil (FU) and liver metastases of colorectal cancer patients. Ann Oncol 1994;5:53.Google Scholar
  60. 60.
    Kunimoto T, Nitta K, Tanaka T, et al. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res 1987;47: 5944–5947.PubMedGoogle Scholar
  61. 61.
    Tsuruo T, Matsuzaki T, Matsushita M, Saito H, Yokokura T. Antitumor effect of CPT-11, a new derivative of camp-tothecin, against pleiotropic drug-resistant tumors in vitro and in vivo. Cancer Chemother Pharmacol 1988;21:71–74.PubMedCrossRefGoogle Scholar
  62. 62.
    Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19:59–71.PubMedCrossRefGoogle Scholar
  63. 63.
    Van de Velde CJH, Sugarbaker PH. Liver Metastases. Amsterdam: Martinus Nijhoff, 1984.CrossRefGoogle Scholar
  64. 64.
    Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938–946.PubMedGoogle Scholar
  65. 65.
    Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990;16:360–365.PubMedGoogle Scholar
  66. 66.
    Haberkorn U, Bellemann ME, Altmann A, et al. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. J Nucl Med 1997;38:1215–1221.PubMedGoogle Scholar
  67. 67.
    Hughes KS, Simons R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988;103:278–288.Google Scholar
  68. 68.
    Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozetti F One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991;78:797–801.PubMedCrossRefGoogle Scholar
  69. 69.
    Scheele J, Stangl R, Altendorf-Hofmann A, Gall FR Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991;110:13–29.PubMedGoogle Scholar
  70. 70.
    Ekberg H, Tranberg KG, Andersson R, et al. Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 1987;11:541–547.PubMedCrossRefGoogle Scholar
  71. 71.
    Cunningham JD, Fong Y, Shriver C, Melendez J, Marx WL, Blumgart LH. One hundred consecutive hepatic resection: blood loss, transfusion, and operative technique. Arch Surg 1994;129:1050–1056.PubMedCrossRefGoogle Scholar
  72. 72.
    Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505–511.PubMedCrossRefGoogle Scholar
  73. 73.
    Baker LH, Talley RW, Matter R, et al. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. Cancer 1976;38:1–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Ehrlichman C, Fine S, Wong A, Elhakim T. Randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988;6:469–475.Google Scholar
  75. 75.
    Petrelli N, Douglas HO, Herrera L, et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 1989;7:1419–1426.PubMedGoogle Scholar
  76. 76.
    Grage TB, Vasilopoulos PP, Shingleton WW, et al. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: a Central Oncology Group study. Surgery 1979;86:550–555.PubMedGoogle Scholar
  77. 77.
    Macdonald JS, Kisner DF, Smythe T, Woolley PV, Smith L, Schein PS. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU. Cancer Treat Rep 1976;60:1597–1600.PubMedGoogle Scholar
  78. 78.
    Buroker T, Kim PN, Groppe C, et al. 5-FU infusion with mitomycin-C versus 5-FU infusion with methyl-CCNU in the treatment of advanced colon cancer. Cancer 1978;42: 1228–1233.PubMedCrossRefGoogle Scholar
  79. 79.
    Conti JA, Kemeny NE, Saltz LB, et al. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol 1996;14:709–715.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Emery A. Minnard
  • Yuman Fong

There are no affiliations available

Personalised recommendations